BG103252A - The use of benzopyranols for the treatment of neurological disorders - Google Patents

The use of benzopyranols for the treatment of neurological disorders

Info

Publication number
BG103252A
BG103252A BG103252A BG10325299A BG103252A BG 103252 A BG103252 A BG 103252A BG 103252 A BG103252 A BG 103252A BG 10325299 A BG10325299 A BG 10325299A BG 103252 A BG103252 A BG 103252A
Authority
BG
Bulgaria
Prior art keywords
treatment
pains
benzopyranols
neurological disorders
neuralgia
Prior art date
Application number
BG103252A
Other languages
Bulgarian (bg)
English (en)
Inventor
Andrew Parsons
Mervyn Thompson
Neil Upton
Johan EVANS
Original Assignee
Smithkline Beecham P.L.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham P.L.C. filed Critical Smithkline Beecham P.L.C.
Publication of BG103252A publication Critical patent/BG103252A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG103252A 1996-09-18 1999-03-15 The use of benzopyranols for the treatment of neurological disorders BG103252A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619492.3A GB9619492D0 (en) 1996-09-18 1996-09-18 Novel treatment
PCT/EP1997/005168 WO1998011890A1 (en) 1996-09-18 1997-09-15 Use of benzopyranols to treat neurological disorders

Publications (1)

Publication Number Publication Date
BG103252A true BG103252A (en) 1999-09-30

Family

ID=10800127

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103252A BG103252A (en) 1996-09-18 1999-03-15 The use of benzopyranols for the treatment of neurological disorders

Country Status (30)

Country Link
EP (1) EP0939630B1 (xx)
JP (1) JP2001500520A (xx)
KR (1) KR20000036184A (xx)
CN (1) CN1230885A (xx)
AP (1) AP9901473A0 (xx)
AR (1) AR008838A1 (xx)
AT (1) ATE270102T1 (xx)
AU (1) AU730465B2 (xx)
BG (1) BG103252A (xx)
BR (1) BR9712030A (xx)
CA (1) CA2266681A1 (xx)
DE (1) DE69729735T2 (xx)
DZ (1) DZ2311A1 (xx)
EA (1) EA199900306A1 (xx)
ES (1) ES2223075T3 (xx)
GB (1) GB9619492D0 (xx)
HU (1) HUP9904638A3 (xx)
ID (2) ID23175A (xx)
IL (1) IL128786A0 (xx)
MA (1) MA24321A1 (xx)
NO (1) NO991292D0 (xx)
NZ (1) NZ334271A (xx)
OA (1) OA10998A (xx)
PE (1) PE109898A1 (xx)
PL (1) PL332313A1 (xx)
SK (1) SK35199A3 (xx)
TR (1) TR199900527T2 (xx)
UY (1) UY24717A1 (xx)
WO (1) WO1998011890A1 (xx)
ZA (1) ZA978359B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7119214B2 (en) * 2004-04-13 2006-10-10 Cephalon France Thio-substituted tricyclic and bicyclic aromatic methanesulfinyl derivatives
MX2010013313A (es) * 2008-06-05 2011-05-30 Minster Res Ltd Tratamientos novedosos.
WO2009147441A2 (en) * 2008-06-05 2009-12-10 Minster Research Limited Novel treatments
WO2011067607A1 (en) * 2009-12-03 2011-06-09 Minster Research Ltd Treatment of infectious diseases
CA2774715C (en) 2009-07-27 2018-04-03 Gilead Sciences, Inc. Fused heterocyclic compounds as ion channel modulators
US20130018091A1 (en) * 2009-12-03 2013-01-17 Peter Blower Treatment of allodynia and hyperalgesia
CN103096977B (zh) 2010-07-02 2017-02-15 吉利德科学公司 作为离子通道调节剂的稠杂环化合物
CA2834164A1 (en) 2011-05-10 2012-11-15 Gilead Sciences, Inc. Fused benzoxazinones as ion channel modulators
NO3175985T3 (xx) 2011-07-01 2018-04-28
TWI478908B (zh) 2011-07-01 2015-04-01 Gilead Sciences Inc 作為離子通道調節劑之稠合雜環化合物
CN106397317B (zh) * 2016-09-26 2019-03-22 天津师范大学 1,2,3,4-四氢喹啉化合物及其合成方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9112721D0 (en) * 1991-06-13 1991-07-31 Smithkline Beecham Plc Novel treatment
US5510375A (en) * 1993-11-19 1996-04-23 Warner-Lambert Company Coumarin derivatives as protease inhibitors and antiviral agents
DE69524871T2 (de) * 1994-06-10 2002-08-22 Smithkline Beecham Plc Benzopyrans und deren verwendung als therapeutische mittel
GB9411635D0 (en) * 1994-06-10 1994-08-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
JP2001500520A (ja) 2001-01-16
ID23175A (id) 2000-03-23
EA199900306A1 (ru) 1999-08-26
GB9619492D0 (en) 1996-10-30
DZ2311A1 (fr) 2002-12-28
PL332313A1 (en) 1999-08-30
OA10998A (en) 2003-03-04
HUP9904638A2 (hu) 2001-05-28
BR9712030A (pt) 1999-08-24
AR008838A1 (es) 2000-02-23
EP0939630B1 (en) 2004-06-30
AU730465B2 (en) 2001-03-08
NZ334271A (en) 2001-03-30
DE69729735D1 (de) 2004-08-05
CN1230885A (zh) 1999-10-06
UY24717A1 (es) 2001-08-27
MA24321A1 (fr) 1998-04-01
IL128786A0 (en) 2000-01-31
AU4704797A (en) 1998-04-14
CA2266681A1 (en) 1998-03-26
HUP9904638A3 (en) 2001-08-28
TR199900527T2 (xx) 1999-06-21
NO991292L (no) 1999-03-17
KR20000036184A (ko) 2000-06-26
SK35199A3 (en) 2000-07-11
DE69729735T2 (de) 2005-07-14
ZA978359B (en) 1999-03-17
ID19542A (id) 1998-07-23
AP9901473A0 (en) 1999-03-31
EP0939630A1 (en) 1999-09-08
ES2223075T3 (es) 2005-02-16
ATE270102T1 (de) 2004-07-15
WO1998011890A1 (en) 1998-03-26
NO991292D0 (no) 1999-03-17
PE109898A1 (es) 1999-03-21

Similar Documents

Publication Publication Date Title
IN172468B (xx)
AU2001236904A1 (en) Deep brain stimulation system for the treatment of parkinson's disease or other disorders
EP0792156A4 (en) METHOD FOR PREVENTING OR TREATING VASCULAR HEMORRAGIES AND ALZHEIMERIC DISEASE
AU2001273574A1 (en) Substituted 5-alkynyl pyrimidines having neurotrophic activity
WO1998020864A3 (en) Use of selected non-steroidal antiinflammatory compounds for the prevention and the treatment of neurodegenerative diseases
GB0108592D0 (en) Therapeutic agents
AP2004003069A0 (en) 3-beta-d-ribofuranosynthiazolo [4-5-d] pyridimine nucleosides and uses thereof.
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
FR2706767B1 (xx)
AU2160492A (en) Treatment of human diseases involving dysregulation or dysfunction of the nervous system
BG103252A (en) The use of benzopyranols for the treatment of neurological disorders
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
MY120976A (en) 2-amino-6-(2-substituted-4-phenoxy)- substituted- pyridines
BG102250A (en) The use of marigold-extracted glycosides for the treatment of psoriasis
ZA977310B (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease.
MY157745A (en) Method of treating of demyelinating diseases or conditions
EP1032556A4 (en) PHARMACEUTICALLY EFFECTIVE COMPOUNDS AND METHODS OF THEIR APPLICATION
WO2000021513A3 (en) Methods for treating multiple sclerosis
GB9425730D0 (en) Compounds
BG104179A (en) Phanquinon administration for the treatment of the alzheimer's disease
IL130586A0 (en) IL6RIL6 chimera for the treatment of demyelinating diseases
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
BG102079A (en) Alkylaminoderivatives of substituted quinoxalin-2,3-dions such as glutamatereceptor antagonists
WO2003020221A3 (en) Method of treating cancerous disease
NZ268914A (en) Use of efaroxan and derivatives to prepare medicaments for treating neurodegenerative diseases especially alzheimer's disease